Suppr超能文献

典型和非典型 κ 阿片受体激动剂在雄性恒河猴中诱导的可观察行为的定量分析。

Quantification of observable behaviors induced by typical and atypical kappa-opioid receptor agonists in male rhesus monkeys.

机构信息

Division of Neurobiology and Behavior Research, Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, MS, 39216, USA.

Department of Pharmaceutical Sciences, University of Kentucky, Lexington, KY, 40536, USA.

出版信息

Psychopharmacology (Berl). 2020 Jul;237(7):2075-2087. doi: 10.1007/s00213-020-05519-7. Epub 2020 May 6.

Abstract

RATIONALE

Kappa-opioid receptor (KOR) agonists are antinociceptive but have side effects that limit their therapeutic utility. New KOR agonists have been developed that are fully efficacious at the KOR but may produce fewer or reduced side effects that are typical of KOR agonists.

OBJECTIVES

We determined behavioral profiles for typical and atypical KOR agonists purported to differ in intracellular-signaling profiles as well as a mu-opioid receptor (MOR) agonist, oxycodone, using a behavioral scoring system based on Novak et al. (Am J Primatol 28:124-138, 1992, Am J Primatol 46:213-227, 1998) and modified to quantify drug-induced effects (e.g., Duke et al. J Pharmacol Exp Ther 366:145-157, 2018).

METHODS

Six adult male rhesus monkeys were administered a range of doses of the typical KOR agonists, U50-488H (0.0032-0.1 mg/kg) and salvinorin A (0.00032-0.01 mg/kg); the atypical KOR agonists, nalfurafine (0.0001-0.001 mg/kg) and triazole 1.1 (0.01-0.32 mg/kg); the MOR agonist, oxycodone (0.0032-0.32 mg/kg); and as controls, cocaine (0.032-0.32 mg/kg) and ketamine (0.32-10 mg/kg). For time-course determinations, the largest dose of each KOR agonist or MOR agonist was administered across timepoints (10-320 min). In mixture conditions, oxycodone (0.1 mg/kg) was followed by KOR-agonist administration.

RESULTS

Typical KOR agonists produced sedative-like and motor-impairing effects. Nalfurafine was similar to typical KOR agonists on most outcomes, and triazole 1.1 produced no effects on its own except for reducing scratch during time-course determinations. In the mixture, all KOR agonists reduced oxycodone-induced scratching, U50-488H and nalfurafine reduced species-typical activity, and U50-488H increased rest/sleep posture.

CONCLUSIONS

Atypical "biased" KOR agonists produce side-effect profiles that are relatively benign (triazole 1.1) or reduced (nalfurafine) compared to typical KOR agonists.

摘要

背景

κ-阿片受体(KOR)激动剂具有抗伤害作用,但副作用限制了其治疗用途。已经开发出新型 KOR 激动剂,它们在 KOR 上完全有效,但可能产生较少或较少的副作用,这些副作用是典型的 KOR 激动剂。

目的

我们使用基于 Novak 等人的行为评分系统(Am J Primatol 28:124-138,1992;Am J Primatol 46:213-227,1998)以及修改后的方法来确定典型和非典型 KOR 激动剂的行为特征,这些激动剂据称在细胞内信号转导特征上有所不同,以及μ-阿片受体(MOR)激动剂奥昔康定,以定量药物诱导的效应(例如,Duke 等人,J Pharmacol Exp Ther 366:145-157,2018)。

方法

6 只成年雄性恒河猴给予一系列剂量的典型 KOR 激动剂 U50-488H(0.0032-0.1mg/kg)和沙利文林 A(0.00032-0.01mg/kg);非典型 KOR 激动剂纳呋拉啡(0.0001-0.001mg/kg)和三唑 1.1(0.01-0.32mg/kg);MOR 激动剂奥昔康定(0.0032-0.32mg/kg);作为对照,可卡因(0.032-0.32mg/kg)和氯胺酮(0.32-10mg/kg)。对于时间过程测定,每种 KOR 激动剂或 MOR 激动剂的最大剂量在时间点(10-320min)之间给药。在混合物条件下,奥昔康定(0.1mg/kg)后给予 KOR 激动剂。

结果

典型的 KOR 激动剂产生镇静样和运动障碍作用。纳呋拉啡在大多数结果上与典型的 KOR 激动剂相似,而三唑 1.1 除了在时间过程测定中减少抓挠外,本身没有产生任何作用。在混合物中,所有 KOR 激动剂均减少了奥昔康定引起的搔抓,U50-488H 和纳呋拉啡减少了物种典型的活动,而 U50-488H 增加了休息/睡眠姿势。

结论

与典型的 KOR 激动剂相比,非典型的“偏向”KOR 激动剂产生的副作用谱相对良性(三唑 1.1)或减少(纳呋拉啡)。

相似文献

5
Kappa opioid agonists reduce oxycodone self-administration in male rhesus monkeys.κ 阿片受体激动剂减少雄性恒河猴的羟考酮自我给药。
Psychopharmacology (Berl). 2020 May;237(5):1471-1480. doi: 10.1007/s00213-020-05473-4. Epub 2020 Jan 31.

引用本文的文献

7
Opioid signaling and design of analgesics.阿片类信号转导与镇痛药设计。
Prog Mol Biol Transl Sci. 2023;195:153-176. doi: 10.1016/bs.pmbts.2022.06.017. Epub 2022 Aug 5.

本文引用的文献

1
Kappa opioid agonists reduce oxycodone self-administration in male rhesus monkeys.κ 阿片受体激动剂减少雄性恒河猴的羟考酮自我给药。
Psychopharmacology (Berl). 2020 May;237(5):1471-1480. doi: 10.1007/s00213-020-05473-4. Epub 2020 Jan 31.
6
Therapeutic Potential of Kappa Opioid Agonists.κ阿片受体激动剂的治疗潜力
Pharmaceuticals (Basel). 2019 Jun 20;12(2):95. doi: 10.3390/ph12020095.
9
Sex differences in neural mechanisms mediating reward and addiction.性别差异在介导奖赏和成瘾的神经机制中。
Neuropsychopharmacology. 2019 Jan;44(1):166-183. doi: 10.1038/s41386-018-0125-6. Epub 2018 Jun 19.
10
Opioid receptors: drivers to addiction?阿片受体:成瘾的驱动力?
Nat Rev Neurosci. 2018 Aug;19(8):499-514. doi: 10.1038/s41583-018-0028-x.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验